Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Why Index Weight Matters discusses the real-world effects of weighting choices on benchmarks and portfolio behavior.
22,027 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
When market swings push shares lower, brilliant dividend stocks can become compelling long-term buys. This article ex...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
A high-profile travel incident sheds light on the cost of risk. This guide translates a jet-crash headline into pract...
While headlines chase the next unicorn, a lesser-known tech stock is quietly gaining traction. Here’s how Wall Street...
Investing in AI requires more than hype. This guide explains how a Nvidia-backed infrastructure stock hand can unlock...
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
A dramatic seed-phrase leak led to a flurry of activity around seized wallets. This piece explores what happened, why...
When a notable investor sells a stake in a popular dating platform, it can raise questions about the stock’s path for...